Cisplatin regulates Sertoli cell expression of transferrin and interleukins

Molecular and Cellular Endocrinology

Volumn 283, Issue 1-2, 2008, Pages 68-75

  Yamaguchi, Kohei ^a   Ishikawa, Tomomoto ^a   Kondo, Yutaka ^a   Fujisawa, Masato ^a  

^a Gunma Univetsity   (Japan)

Author keywords

Cisplatin; Cyclooxygenase; Cytokines; Mitogen activated protein kinase; Testis; Transferrin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARBACYCLIN; CISPLATIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFERRIN;

ARTICLE; ENZYME ACTIVATION; HORMONE SYNTHESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERTOLI CELL; SPERMATOGENESIS; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CISPLATIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; SERTOLI CELLS; TRANSFERRIN;

EID: 39149137195     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.11.021     Document Type: Article

References (49)

1. Bauche F., Stephan J.P., Touzalin A.M., and Jegou B. In vitro regulation of an inducible-type NO synthase in the rat seminiferous tubule cells. Biol. Reprod. 58 (1998) 431-438
2. Brennemann W., Stoffel-Wagner B., Helmers A., Mezger J., Jager N., and Klingmuller D. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J. Urol. 158 (1997) 844-850
3. Breyer M.D., Hebert R.L., and Breyer R.M. Prostanoid receptors and the urogenital tract. Curr. Opin. Investig. Drugs 4 (2003) 1343-1353
4. Carreau S., Papadopoulos V., Boujrad N., and Drosdowsky M.A. Effects of cisplatin and bleomycin on mature rat Leydig cell testosterone production. J. Steroid Biochem. 30 (1988) 449-451
5. Cobb M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71 (1999) 479-500
6. Crepieux P., Marion S., Martinat N., Fafeur V., Vern Y.L., Kerboeuf D., Guillou F., and Reiter E. The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation. Oncogene 20 (2001) 4696-4709
7. Cudicini C., Kercret H., Touzalin A.M., Ballet F., and Jegou B. Vectorial production of interleukin 1 and interleukin 6 by rat Sertoli cells cultured in a dual culture compartment system. Endocrinology 138 (1997) 2863-2870
8. Fujisawa M., Tatsumi N., Fujioka H., Kanzaki M., Okuda Y., Arakawa S., and Kamidono S. Nitric oxide production of rat Leydig and Sertoli cells is stimulated by round spermatid factor(s). Mol. Cell. Endocrinol. 160 (2000) 99-105
9. Gerard N., Syed V., and Jegou B. Lipopolysaccharide, latex beads and residual bodies are potent activators of Sertoli cell interleukin-1 alpha production. Biochem. Biophys. Res. Commun. 185 (1992) 154-161
10. Hakovirta H., Syed V., Jegou B., and Parvinen M. Function of interleukin-6 as an inhibitor of meiotic DNA synthesis in the rat seminiferous epithelium. Mol. Cell. Endocrinol. 108 (1995) 193-198
11. Holmes S.D., Bucci L.R., Lipshultz L.I., and Smith R.G. Transferrin binds specifically to pachytene spermatocytes. Endocrinology 113 (1983) 1916-1918
12. Huang H.F., Pogach L.M., Nathan E., and Giglio W. Acute and chronic effects of cisplatinum upon testicular function in the rat. J. Androl. 11 (1990) 436-445
13. Huleihel M., and Lunenfeld E. Regulation of spermatogenesis by paracrine/autocrine testicular factors. Asian J. Androl. 6 (2004) 259-268
14. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 9265-9269
15. Ishikawa T., Hwang K., Lazzarino D., and Morris P.L. Sertoli cell expression of steroidogenic acute regulatory protein-related lipid transfer 1 and 5 domain-containing proteins and sterol regulatory element binding protein-1 are interleukin-1beta regulated by activation of c-Jun N-terminal kinase and cyclooxygenase-2 and cytokine induction. Endocrinology 146 (2005) 5100-5111
16. Ishikawa T., and Morris P.L. A multistep kinase-based sertoli cell autocrine-amplifying loop regulates prostaglandins, their receptors, and cytokines. Endocrinology 147 (2006) 1706-1716
17. Ishikawa T., and Morris P.L. Interleukin-1beta signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells. Endocrinology 147 (2006) 5424-5430
18. Kanzaki M., and Morris P.L. Identification and regulation of testicular interferon-gamma (IFNgamma) receptor subunits: IFNgamma enhances interferon regulatory factor-1 and interleukin-1beta converting enzyme expression. Endocrinology 139 (1998) 2636-2644
19. Khan S.A., and Nieschlag E. Interleukin-1 inhibits follitropin-induced aromatase activity in immature rat Sertoli cells in vitro. Mol. Cell. Endocrinol. 75 (1991) 1-7
20. Koyama T., Mikami T., Koyama T., Imakiire A., Yamamoto K., Toyota H., and Mizuguchi J. Apoptosis induced by chemotherapeutic agents involves c-Jun N-terminal kinase activation in sarcoma cell lines. J. Orthop. Res. 24 (2006) 1153-1162
21. Legue F., Guitton N., Brouazin-Jousseaume V., Colleu-Durel S., Nourgalieva K., and Chenal C. IL-6 a key cytokine in in vitro and in vivo response of Sertoli cells to external gamma irradiation. Cytokine 16 (2001) 232-238
22. Leng M., and Brabec V. DNA adducts of cisplatin, transplatin and platinum-intercalating drugs. IARC Sci. Publ. (1994) 339-348
23. Levresse V., Marek L., Blumberg D., and Heasley L.E. Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells. Mol. Pharmacol. 62 (2002) 689-697
24. Lin T., Wang D., Nagpal M.L., Chang W., and Calkins J.H. Down-regulation of Leydig cell insulin-like growth factor-I gene expression by interleukin-1. Endocrinology 130 (1992) 1217-1224
25. Loehrer P.J., and Einhorn L.H. Drugs five years later. Cisplatin. Ann. Intern. Med. 100 (1984) 704-713
26. Mansouri A., Ridgway L.D., Korapati A.L., Zhang Q., Tian L., Wang Y., Siddik Z.H., Mills G.B., and Claret F.X. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J. Biol. Chem. 278 (2003) 19245-21956
27. Monsees T.K., Franz M., Gebhardt S., Winterstein U., Schill W.B., and Hayatpour J. Sertoli cells as a target for reproductive hazards. Andrologia 32 (2000) 239-246
28. Nambu A., Kumamoto Y., and Mikuma N. Effects of anti-cancer agents on cultured rat Sertoli cells. Nippon Hinyokika Gakkai Zasshi 86 (1995) 1132-1136
29. Okuda Y., Bardin C.W., Hodgskin L.R., and Morris P.L. Interleukins-1 alpha and -1 beta regulate interleukin-6 expression in Leydig and Sertoli cells. Recent Prog. Horm. Res. 50 (1995) 367-372
30. Okuda Y., Sun X.-R., and Morris P.L. Interleukin-6 (IL-6) mRNAs expressed in Leydig and Sertoli cells are regulated by cytokines, gonadotropins and neuropeptides. Endocrine 2 (1994) 617-624
31. Parvinen M., Soder O., Mali P., Froysa B., and Ritzen E.M. In vitro stimulation of stage-specific deoxyribonucleic acid synthesis in rat seminiferous tubule segments by interleukin-1 alpha. Endocrinology 129 (1991) 1614-1620
32. Petersen C., Svechnikov K., Froysa B., and Soder O. The p38 MAPK pathway mediates interleukin-1-induced Sertoli cell proliferation. Cytokine 32 (2005) 51-59
33. Petersen C., Boitani C., Froysa B., and Soder O. Interleukin-1 is a potent growth factor for immature rat sertoli cells. Mol. Cell. Endocrinol. 186 (2002) 37-47
34. Piquet P.C., Gomez E., Cudicini C., Stephan J.P., Dejucq N., and Jegou B. Cytokines and spermatogenesis. In: Hedon B., Bringer J., and Mares P. (Eds). Proceedings of the 5th World Congress on Fertility and Sterility (1995), Parthenon, Publishing, Group, London 249-255
35. Pogach L.M., Lee Y., Gould S., Giglio W., Meyenhofer M., and Huang H.F. Characterization of cis-platinum-induced Sertoli cell dysfunction in rodents. Toxicol. Appl. Pharmacol. 98 (1989) 350-361
36. Pomerantz D.K. Effects of in vivo gonadotropin treatment on estrogen levels in the testis of the immature rat. Biol. Reprod. 21 (1979) 1247-1255
37. Potapova O., Haghighi A., Bost F., Liu C., Birrer M.J., Gjerset R., and Mercola D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272 (1997) 14041-14044
38. Sanchez-Perez I., Murguia J.R., and Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16 (1998) 533-540
39. Seaman F., Sawhney P., Giammona C.J., and Richburg J.H. Cisplatin-induced pulse of germ cell apoptosis precedes long-term elevated apoptosis rates in C57/BL/6 mouse testis. Apoptosis 8 (2003) 101-108
40. Schilsky R.L., Lewis B.J., Sherins R.J., and Young R.C. Gonadal dysfunction in patients receiving chemotherapy for cancer. Ann. Intern. Med. 93 (1980) 109-114
41. Stephan J.P., Guillemois C., Jegou B., and Bauche F. Nitric oxide production by Sertoli cells in response to cytokines and lipopolysaccharide. Biochem. Biophys. Res. Commun. 213 (1995) 218-224
42. Stuehr D.J., and Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 7738-7742
43. Stumpp T., Freymuller E., and Miraglia S.M. Sertoli cell function in albino rats treated with etoposide during prepubertal phase. Histochem. Cell. Biol. 126 (2006) 353-361
44. Syed V., Stephan J.P., Gerard N., Legrand A., Parvinen M., Bardin C.W., and Jegou B. Residual bodies activate Sertoli cell interleukin-1 alpha (IL-1 alpha) release, which triggers IL-6 production by an autocrine mechanism, through the lipoxygenase pathway. Endocrinology 136 (1995) 3070-3078
45. Syed V., Gerard N., Kaipia A., Bardin C.W., Parvinen M., and Jegou B. Identification, ontogeny, and regulation of an interleukin-6-like factor in the rat seminiferous tubule. Endocrinology 132 (1993) 293-299
46. Sylvester S.R., and Griswold M.D. The testicular iron shuttle: a "nurse" function of the Sertoli cells. J. Androl. 15 (1994) 381-385
47. Walch L., and Morris P.L. Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors. Endocrinology 143 (2002) 3276-3283
48. Wang D., Nagpal M.L., Shimasaki S., Ling N., and Lin T. Interleukin-1 induces insulin-like growth factor binding protein-3 gene expression and protein production by Leydig cells. Endocrinology 136 (1995) 4049-4055
49. Xie Q., and Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leukocyte Biol. 56 (1994) 576-582